StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

CNBX Pharmaceuticals's gross profit for the twelve months ending Feb 28, 2018 was $8.13K, down 92.0% year over year. For fiscal 2017 it was $5.68K, down 94.9% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2017Aug 31, 2017$5.68K-94.9%
FY2016Aug 31, 2016$112.50K–
FY2015Aug 31, 2015$0–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026May 31, 2026$0-100.0%
Q2 FY2026CQ1 2026Feb 28, 2026$0–
Q3 FY2025CQ2 2025May 31, 2025$0-100.0%
Q2 FY2025CQ1 2025Feb 28, 2025$0-100.0%
Q2 FY2024CQ1 2024Feb 29, 2024$34.42K+1857.7%
Q2 FY2023CQ1 2023Feb 28, 2023$0-100.0%
Q1 FY2019CQ4 2018Nov 30, 2018$3.31K+110.4%
Q2 FY2018CQ1 2018Feb 28, 2018$1.93K+55.3%
Q1 FY2018CQ4 2017Nov 30, 2017$1.76K–
Q4 FY2017CQ3 2017Aug 31, 2017$2.87K-94.3%
Q3 FY2017CQ2 2017May 31, 2017$1.57K–
Q2 FY2017CQ1 2017Feb 28, 2017$1.24K–
Q1 FY2017CQ4 2016Nov 30, 2016$0–
Q4 FY2016CQ3 2016Aug 31, 2016$50.00K–

More CNBX Pharmaceuticals figures

See a number that looks wrong?